Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VICR✓SelectedUSD · VICRGSK vs VICR performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs VICR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.9%
VICR return
+66.1%
Excess return
-59.2%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioVICRExcessAlpha
1D-1.6%-2.8%+1.2%-1.7%
7D-4.7%-14.1%+9.4%-5.3%
30D-4.7%-30.7%+26.0%-6.0%
3M-8.8%-34.9%+26.1%-10.1%
6M-4.6%-41.9%+37.2%-6.7%
YTD+1.0%+29.1%-28.1%-2.3%
1Y+6.9%+66.4%-59.5%+1.2%
All+6.9%+66.1%-59.2%+1.2%

Cumulative growth

Daily Returns

Daily percentage return beside VICR.

Daily Out/Under-Performance

Portfolio return minus VICR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VICR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded VICR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling